A Phase 3 Multicentre, Randomized, Placebo-controlled and Ustekinumab Active, Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Plaque Psoriasis – ICONIC ASCEND

  • Lai, Francis (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date14/05/25 → 13/05/30

Clinical Trial Phase

  • Phase III (a & b)